Skip to main content

Replication of human immunodeficiency virus type 1 from entry to exit

International Journal of Hematology volume 84, pages 23–30 (2006)Cite this article

Abstract

It has been 25 years since the recognition of the disease acquired immunodeficiency syndrome (AIDS) in homosexual men in the United States. Much molecular progress in understanding the replication of the human immunodeficiency virus (HIV) has been advanced. Here, we review in a nonexhaustive manner our current knowledge of the replication of HIV-1 inside human cells from entry to exit of the virus.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. Woodbury, NY. Cold Spring Harbor Laboratory Press; 1999.

    Google Scholar 

  2. Lusso P. HIV and the chemokine system: 10 years later. EMBO J. 2006;25:447–456.

    CAS  PubMed Central  PubMed  Google Scholar 

  3. Hartley O, Klasse PJ, Sattentau QJ, Moore JP. V3: HIV’s switch-hitter. AIDS Res Hum Retroviruses. 2005;21:171–189.

    CAS  PubMed  Google Scholar 

  4. Clapham PR, McKnight A. Cell surface receptors, virus entry and tropism of primate lentiviruses. J Gen Virol. 2002;83:1809–1829.

    CAS  PubMed  Google Scholar 

  5. Schuitemaker H., Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell—tropic virus population. J Virol. 1992;66:1354–1360.

    CAS  PubMed Central  PubMed  Google Scholar 

  6. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1—infected individuals. J Exp Med. 1997;185:621–628.

    CAS  PubMed Central  PubMed  Google Scholar 

  7. Melikyan GB, Markosyan RM, Hemmati H, Delmedico MK, Lambert DM, Cohen FS. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol. 2000;151:413–423.

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Fassati A, Goff SP. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol. 2001;75:3626–3635.

    CAS  PubMed Central  PubMed  Google Scholar 

  9. McDonald D, Vodicka MA, Lucero G, et al. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol. 2002;159:441–452.

    CAS  PubMed Central  PubMed  Google Scholar 

  10. Zheng YH, Peterlin BM. Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells. Retrovirology. 2005;2:25.

    PubMed Central  PubMed  Google Scholar 

  11. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys. Nature. 2004;427:848–853.

    CAS  PubMed  Google Scholar 

  12. Ylinen LM, Keckesova Z, Wilson SJ, Ranasinghe S, Towers GJ. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SI Vmac by TRIM5alpha alleles. J Virol. 2005;79:11580–11587.

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Newman EN, Holmes RK, Craig HM, et al. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol. 2005;15:166–170.

    CAS  PubMed  Google Scholar 

  14. Sheehy AM, NC Gaddis, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002;418:646–650.

    CAS  PubMed  Google Scholar 

  15. Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med. 2003;9:1398–1403.

    CAS  PubMed  Google Scholar 

  16. Gatignol A, Buckler-White A, Berkhout B, Jeang KT. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science. 1991;251:1597–1600.

    CAS  PubMed  Google Scholar 

  17. Gatignol A, Laine S, Clerzius G. Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology. 2005;2:65.

    PubMed Central  PubMed  Google Scholar 

  18. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740–744.

    CAS  PubMed Central  PubMed  Google Scholar 

  19. Haase AD, Jaskiewicz L, Zhang H, et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005;6:961–967.

    CAS  PubMed Central  PubMed  Google Scholar 

  20. Hannon GJ. RNA interference. Nature. 2002;418:244–251.

    CAS  PubMed  Google Scholar 

  21. Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity. 2005;22:607–619.

    CAS  PubMed  Google Scholar 

  22. Omoto S, Ito M, Tsutsumi Y, et al. HIV-1 nef suppression by virally encoded microRNA. Retrovirology. 2004;1:44.

    PubMed Central  PubMed  Google Scholar 

  23. Yeung ML, Bennasser Y, Le SY, Jeang KT. siRNA, miRNA and HIV: promises and challenges. Cell Res. 2005;15:935–946.

    CAS  PubMed  Google Scholar 

  24. Berkhout B, Haasnoot J. The interplay between virus infection and the cellular RNA interference machinery. FEBS Lett. 2006;580:2896–2902.

    CAS  PubMed  Google Scholar 

  25. Yeung ML, Bennasser Y, Myers TG, Jiang G, Benkirane M, Jeang KT. Changes in microRNA expression profiles in HIV-1—transfected human cells. Retrovirology. 2005;2:81.

    PubMed Central  PubMed  Google Scholar 

  26. Sherman MP, Greene WC. Slipping through the door: HIV entry into the nucleus. Microbes Infect. 2002;4:67–73.

    CAS  PubMed  Google Scholar 

  27. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell. 2000;101:173–185.

    CAS  PubMed  Google Scholar 

  28. Woischnik M, Moraes CT. Pattern of organization of human mitochondrial pseudogenes in the nuclear genome. Genome Res. 2002;12:885–893.

    CAS  PubMed Central  PubMed  Google Scholar 

  29. Rocher C, Letellier T, Copeland WC, Lestienne P. Base composition at mtDNA boundaries suggests a DNA triple helix model for human mitochondrial DNA large-scale rearrangements. Mol Genet Metab. 2002;76:123–132.

    CAS  PubMed  Google Scholar 

  30. Limon A, Nakajima N, Lu R, Ghory HZ, Engelman A. Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap. J Virol. 2002;76:12078–12086.

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521–529.

    CAS  PubMed  Google Scholar 

  32. Mitchell RS, Beitzel BF, Schroder AR, et al. Retroviral DNA integration:ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2004;2:E234.

    PubMed Central  PubMed  Google Scholar 

  33. Nisole S, Saib A. Early steps of retrovirus replicative cycle. Retrovirology. 2004;1:9.

    PubMed Central  PubMed  Google Scholar 

  34. Wu Y. HIV-1 gene expression: lessons from provirus and non-integrated DNA. Retrovirology. 2004;1:13.

    CAS  PubMed Central  PubMed  Google Scholar 

  35. Demarchi F, D’Agaro P, Falaschi A, Giacca M. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J Virol. 1993;67:7450–7460.

    CAS  PubMed Central  PubMed  Google Scholar 

  36. el Kharroubi A, Verdin E. Protein-DNA interactions within DNase I—hypersensitive sites located downstream of the HIV-1 promoter. J Biol Chem. 1994;269:19916–19924.

    PubMed  Google Scholar 

  37. Verdin E. DNase I—hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J Virol. 1991;65:6790–6799.

    CAS  PubMed Central  PubMed  Google Scholar 

  38. Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 2000;28:663–668.

    CAS  PubMed Central  PubMed  Google Scholar 

  39. Rosen CA, Sodroski JG, Haseltine WA. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell. 1985;41:813–823.

    CAS  PubMed  Google Scholar 

  40. Dingwall C, Ernberg I, Gait MJ, et al. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A. 1989;86:6925–6929.

    CAS  PubMed Central  PubMed  Google Scholar 

  41. Berkhout B, Silverman RH, Jeang KT. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell. 1989;59:273–282.

    CAS  PubMed  Google Scholar 

  42. Berkhout B, Gatignol A, Rabson AB, Jeang KT. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell. 1990;62:757–767.

    CAS  PubMed  Google Scholar 

  43. Jeang KT, Xiao H, Rich EA. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem. 1999;274:28837–28840.

    CAS  PubMed  Google Scholar 

  44. Marzio G, Tyagi M, Gutierrez MI, Giacca M. HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci U S A. 1998;95:13519–13524.

    CAS  PubMed Central  PubMed  Google Scholar 

  45. Hottiger MO, Nabel GJ. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J Virol. 1998;72:8252–8256.

    CAS  PubMed Central  PubMed  Google Scholar 

  46. Benkirane M, Chun RF, Xiao H, et al. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem. 1998;273:24898–24905.

    CAS  PubMed  Google Scholar 

  47. Jeang KT, Chun R, Lin NH, Gatignol A, Glabe CG, Fan H. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J Virol. 1993;67:6224–6233.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Kashanchi F, Piras G, Radonovich MF, et al. Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature. 1994;367:295–299.

    CAS  PubMed  Google Scholar 

  49. Brady J, Kashanchi F. Tat gets the “green” light on transcription initiation. Retrovirology. 2005;2:69.

    PubMed Central  PubMed  Google Scholar 

  50. Raha T, Cheng SW, Green MR: HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TA F s. PLoS Biol. 2005;3:e44.

    PubMed Central  PubMed  Google Scholar 

  51. Garber ME, Wei P, KewalRamani VN, et al. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 1998;12:3512–3527.

    CAS  PubMed Central  PubMed  Google Scholar 

  52. Marshall NF, Price DH. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol Cell Biol. 1992;12:2078–2090.

    CAS  PubMed Central  PubMed  Google Scholar 

  53. Zhou M, Deng L, Lacoste V, et al. Coordination of transcription factor phosphorylation and histone methylation by the P-TE Fb kinase during human immunodeficiency virus type 1 transcription. J Virol. 2004;78:13522–13533.

    CAS  PubMed Central  PubMed  Google Scholar 

  54. Ramanathan Y, Reza SM, Young TM, Mathews MB, Pe’ery T. Human and rodent transcription elongation factor P-TE Fb: interactions with human immunodeficiency virus type 1 tat and carboxyterminal domain substrate. J Virol. 1999;73:5448–5458.

    CAS  PubMed Central  PubMed  Google Scholar 

  55. Nekhai S, Shukla RR, Kumar A. A human primary T-lympho-cyte—derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity. J Virol. 1997;71:7436–7441.

    CAS  PubMed Central  PubMed  Google Scholar 

  56. Isel C, Karn J. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. J Mol Biol. 1999;290:929–941.

    CAS  PubMed  Google Scholar 

  57. Herrmann CH, Rice AP. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA poly-merase II. candidate for a Tat cofactor. J Virol. 1995;69:1612–1620.

    CAS  PubMed Central  PubMed  Google Scholar 

  58. Fujinaga K, Cujec TP, Peng J, et al. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J Virol. 1998;72:7154–7159.

    CAS  PubMed Central  PubMed  Google Scholar 

  59. Schwartz S, Felber BK, Fenyo EM, Pavlakis GN. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol. 1990;64:5448–5456.

    CAS  PubMed Central  PubMed  Google Scholar 

  60. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol. 1993;67:6365–6378.

    CAS  PubMed Central  PubMed  Google Scholar 

  61. Cochrane AW, McNally MT, Mouland AJ. The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology. 2006;3:18.

    PubMed Central  PubMed  Google Scholar 

  62. Si Z, Amendt BA, Stoltzfus CM. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res. 1997;25:861–867.

    CAS  PubMed Central  PubMed  Google Scholar 

  63. Madsen JM, Stoltzfus CM. A suboptimal 5′ splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology. 2006;3:10.

    PubMed Central  PubMed  Google Scholar 

  64. Jacquenet S, Decimo D, Muriaux D, Darlix JL. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology. 2005;2:33.

    PubMed Central  PubMed  Google Scholar 

  65. Caputi M, Mayeda A, Krainer AR, Zahler AM. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. EMBO J. 1999;18:4060–4067.

    CAS  PubMed Central  PubMed  Google Scholar 

  66. Caputi M, Zahler AM. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. EMBO J. 2002;21:845–855.

    CAS  PubMed Central  PubMed  Google Scholar 

  67. Caputi M, Freund M, Kammler S, Asang C, Schaal H. A bidirectional SF2/ASF- and S Rp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J Virol. 2004;78:6517–6526.

    CAS  PubMed Central  PubMed  Google Scholar 

  68. Amendt BA, Si ZH, Stoltzfus CM. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol. 1995;15:6480.

    CAS  PubMed  Google Scholar 

  69. Amendt BA, Hesslein D, Chang LJ, Stoltzfus CM. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol Cell Biol. 1994;14:3960–3970.

    CAS  PubMed Central  PubMed  Google Scholar 

  70. Tange TO, Damgaard CK, Guth S, Valcarcel J, Kjems J. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J. 2001;20:5748–5758.

    CAS  PubMed Central  PubMed  Google Scholar 

  71. Chang DD, Sharp PA. Regulation by HIV Rev depends upon recognition of splice sites. Cell. 1989;59:789–795.

    CAS  PubMed  Google Scholar 

  72. Hope TJ, McDonald D, Huang XJ, Low J, Parslow TG. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus. J Virol. 1990;64:5360–5366.

    CAS  PubMed Central  PubMed  Google Scholar 

  73. Kjems J, Brown M, Chang DD, Sharp PA. Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc Natl Acad Sci U S A. 1991;88:683–687.

    CAS  PubMed Central  PubMed  Google Scholar 

  74. Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. The HIV-1 revtrans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 1989;338:254–257.

    CAS  PubMed  Google Scholar 

  75. Zapp ML, Green MR. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature. 1989;342:714–716.

    CAS  PubMed  Google Scholar 

  76. Bogerd HP, Echarri A, Ross TM, Cullen BR. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1. J Virol. 1998;72:8627–8635.

    CAS  PubMed Central  PubMed  Google Scholar 

  77. Askjaer P, Jensen TH, Nilsson J, Englmeier L, Kjems J. The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. J Biol Chem. 1998;273:33414–33422.

    CAS  PubMed  Google Scholar 

  78. Fornerod M, Ohno M, Yoshida M, Mattaj IW. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 1997;90:1051–1060.

    CAS  PubMed  Google Scholar 

  79. Fukuda M, Asano S, Nakamura T, et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature. 1997;390:308–311.

    CAS  PubMed  Google Scholar 

  80. Neville M, Stutz F, Lee L, Davis LI, Rosbash M. The importin-betafamily member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol. 1997;7:767–775.

    CAS  PubMed  Google Scholar 

  81. Otero GC, Harris ME, Donello JE, Hope TJ. Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element. J Virol. 1998;72:7593–7597.

    CAS  PubMed Central  PubMed  Google Scholar 

  82. Clouse KN, Luo MJ, Zhou Z, Reed RA. Ran-independent pathway for export of spliced mRNA. Nat Cell Biol. 2001;3:97–99.

    CAS  PubMed  Google Scholar 

  83. Herold A, Klymenko T, Izaurralde E. NXF1/p15 heterodimers are essential for mRNA nuclear export in Drosophila. RNA. 2001;7:1768–1780.

    CAS  PubMed Central  PubMed  Google Scholar 

  84. Pasquinelli AE, Ernst RK, Lund E, et al. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway. EMBO J. 1997;16:7500–7510.

    CAS  PubMed Central  PubMed  Google Scholar 

  85. Saavedra C, Felber B, Izaurralde E. The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export. Curr Biol. 1997;7:619–628.

    CAS  PubMed  Google Scholar 

  86. Dayton AI. Within you, without you: HIV-1 Rev and RNA export. Retrovirology. 2004;1:35.

    PubMed Central  PubMed  Google Scholar 

  87. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell. 2004;119:381–392.

    CAS  PubMed  Google Scholar 

  88. Fang J, Acheampong E, Dave R, Wang F, Mukhtar M, Pomerantz RJ. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes. Virology. 2005;336:299–307.

    CAS  PubMed  Google Scholar 

  89. Schmitt C, Kobbe C, von Bachi A, et al. Dbp5, a DEAD-box protein required for mRNA export, is recruited to the cytoplasmic fibrils of nuclear pore complex via a conserved interaction with CAN/Nup159p. EMBO J. 1999;18:4332–4347.

    CAS  PubMed Central  PubMed  Google Scholar 

  90. van’t Wout AB, Lehrman GK, Mikheeva SA, et al. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol. 2003;77:1392–1402.

    Google Scholar 

  91. Levin JG, Grimley PM, Ramseur JM, Berezesky IK. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol. 1974;14:152–161.

    CAS  PubMed Central  PubMed  Google Scholar 

  92. Butsch M, Boris-Lawrie K. Destiny of unspliced retroviral RNA. ribosome and/or virion? J Virol. 2002;76:3089–3094.

    CAS  PubMed Central  PubMed  Google Scholar 

  93. Dorman N, Lever A. Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus. J Virol. 2000;74:11413–11417.

    CAS  PubMed Central  PubMed  Google Scholar 

  94. Kaye JF, Lever AM. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J Virol. 1999;73:3023–3031.

    CAS  PubMed Central  PubMed  Google Scholar 

  95. Griffin SD, Allen JF, Lever AM. The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity. J Virol. 2001;75:12058–2069.

    CAS  PubMed Central  PubMed  Google Scholar 

  96. Poon DT, Chertova EN, Ott DE. Human immunodeficiency virus type 1 preferentially encapsidates genomic RN As that encode Pr55(Gag): functional linkage between translation and RNA packaging. Virology. 2002;293:368–378.

    CAS  PubMed  Google Scholar 

  97. Zeffman A, S Hassard, G Varani, Lever A. The major HIV-1 packaging signal is an extended bulged stem loop whose structure is altered on interaction with the Gag polyprotein. J Mol Biol. 2000;297:877–893.

    CAS  PubMed  Google Scholar 

  98. De Guzman RN, Wu ZR, Stalling CC, Pappalardo L, Borer PN, Summers MF. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science. 1998;279:384–388.

    PubMed  Google Scholar 

  99. Greatorex J. The retroviral RNA dimer linkage: different structures may reflect different roles. Retrovirology. 2004;1:22.

    PubMed Central  PubMed  Google Scholar 

  100. Ooms M, Huthoff H, Russell R, Liang C, Berkhout B. A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol. 2004;78:10814–10819.

    CAS  PubMed Central  PubMed  Google Scholar 

  101. Cruceanu M, Urbaneja MA, Hixson CV, et al. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res. 2006;34:593–605.

    CAS  PubMed Central  PubMed  Google Scholar 

  102. Poole E, Strappe P, Mok HP, Hicks R, Lever AM. HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic. 2005;6:741–755.

    CAS  PubMed  Google Scholar 

  103. Beriault V, Clement JF, Levesque K, et al. A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag, and Vpr localization. J Biol Chem. 2004;279:44141–44153.

    CAS  PubMed  Google Scholar 

  104. Chatel-Chaix L, Clement JF, Martel C, et al. Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol Cell Biol. 2004;24:2637–2648.

    CAS  PubMed Central  PubMed  Google Scholar 

  105. Sfakianos JN, LaCasse RA, Hunter E. The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell. Traffic. 2003;4:660–670.

    CAS  PubMed  Google Scholar 

  106. Basyuk E, Galli T, Mougel M, Blanchard JM, Sitbon M, Bertrand E. Retroviral genomic RN As are transported to the plasma membrane by endosomal vesicles. Dev Cell. 2003;5:161–174.

    CAS  PubMed  Google Scholar 

  107. Pelchen-Matthews A, Kramer B, Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol. 2003;162:443–455.

    CAS  PubMed Central  PubMed  Google Scholar 

  108. Campbell S, Vogt VM. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol. 1995;69:6487–6497.

    CAS  PubMed Central  PubMed  Google Scholar 

  109. Alfadhli A, Dhenub TC, Still A, Barklis E. Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly. J Virol. 2005;79:14498–14506.

    CAS  PubMed Central  PubMed  Google Scholar 

  110. Morikawa Y. HIV capsid assembly. Curr HIV Res. 2003;1:1–14.

    CAS  PubMed  Google Scholar 

  111. Morellet N, Druillennec S, Lenoir C, Bouaziz S, Roques BP. Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging. Protein Sci. 2005;14:375–386.

    CAS  PubMed Central  PubMed  Google Scholar 

  112. Spearman P, Wang JJ, Vander Heyden N, Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol. 1994;68:3232–3242.

    CAS  PubMed Central  PubMed  Google Scholar 

  113. Sandefur S, Smith RM, Varthakavi V, Spearman P. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J Virol. 2000;74:7238–7249.

    CAS  PubMed Central  PubMed  Google Scholar 

  114. Martin-Serrano J, Zang T, Bieniasz PD. Role of ESCRT-I in retro-viral budding. J Virol. 2003;77:4794–4804.

    CAS  PubMed Central  PubMed  Google Scholar 

  115. Garrus JE, Kvon Schwedler U, Pornillos OW, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 2001;107:55–65.

    CAS  PubMed  Google Scholar 

  116. Ono A, Freed EO. Cell-type—dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J Virol. 2004;78:1552–1563.

    CAS  PubMed Central  PubMed  Google Scholar 

  117. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med. 2004;199:283–293.

    CAS  PubMed Central  PubMed  Google Scholar 

  118. Briggs JA, Grunewald K, Glass B, Forster F, Krausslich HG, Fuller SD. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure. 2006;14:15–20.

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. University of Cambridge Department of Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom

    Andrew M. L. Lever

  2. Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

    Kuan-Teh Jeang

Authors
  1. Andrew M. L. Lever
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kuan-Teh Jeang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Andrew M. L. Lever or Kuan-Teh Jeang.

About this article

Cite this article

Lever, A.M.L., Jeang, KT. Replication of human immunodeficiency virus type 1 from entry to exit. Int J Hematol 84, 23–30 (2006). https://doi.org/10.1532/IJH97.06112

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.06112

Key words

  • HIV-1
  • AIDS
  • RNAi
  • APOBEC3G
  • Integration
  • Reverse transcription
  • Tat
  • Rev